| Jack Cukierman, MD | |
|
4247 Maple Rd, Amherst, NY 14226 | |
| (716) 835-9871 | |
| (716) 838-3084 |
| Full Name | Jack Cukierman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 49 Years |
| Location | 4247 Maple Rd, Amherst, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114995388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 127463 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wny Medical Pc | 9335191733 | 41 |
News Archive
Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Researchers recommend the inclusion of optical coherence tomography anatomic classification with fluorescein angiography grading to identify initial neovascular lesion subtypes in newly diagnosed age-related macular degeneration.
Schonfeld, a University of Illinois at Chicago professor of electrical and computer engineering, is studying gene expression and interactions in ways that are analogous to the workings of electrical or computer networks. He is project director and principal investigator of a four-year, $1.2 million National Institutes of Health grant.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
› Verified 5 days ago
| Entity Name | Wny Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154421246 PECOS PAC ID: 9335191733 Enrollment ID: O20050214000821 |
News Archive
Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Researchers recommend the inclusion of optical coherence tomography anatomic classification with fluorescein angiography grading to identify initial neovascular lesion subtypes in newly diagnosed age-related macular degeneration.
Schonfeld, a University of Illinois at Chicago professor of electrical and computer engineering, is studying gene expression and interactions in ways that are analogous to the workings of electrical or computer networks. He is project director and principal investigator of a four-year, $1.2 million National Institutes of Health grant.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jack Cukierman, MD 4247 Maple Rd, Amherst, NY 14226 Ph: (716) 835-9871 | Jack Cukierman, MD 4247 Maple Rd, Amherst, NY 14226 Ph: (716) 835-9871 |
News Archive
Northstar Healthcare Inc. today announced its financial results for the fourth quarter and year ended December 31, 2010.
Researchers recommend the inclusion of optical coherence tomography anatomic classification with fluorescein angiography grading to identify initial neovascular lesion subtypes in newly diagnosed age-related macular degeneration.
Schonfeld, a University of Illinois at Chicago professor of electrical and computer engineering, is studying gene expression and interactions in ways that are analogous to the workings of electrical or computer networks. He is project director and principal investigator of a four-year, $1.2 million National Institutes of Health grant.
Bristol-Myers Squibb Company and AstraZeneca today announced that the European Commission has approved a label update for ONGLYZA in the treatment of adults with type 2 diabetes who have moderate or severe renal impairment. The approved dosage for the patient group is a new once-daily 2.5 mg dose.
Biomedical engineers at Duke University have reconfigured a popular drug-delivery technology to evade immune responses that have halted some clinical trials.
› Verified 5 days ago
Ahmad Mafi, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3980a Sheridan Dr Ste 200, Amherst, NY 14226 Phone: 716-833-2200 | |
Dawn S Harbatkin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3980 Sheridan Dr, Amherst, NY 14226 Phone: 716-250-2000 Fax: 716-819-3821 | |
Richard Vienne, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1185 Sweet Home Rd, Amherst, NY 14226 Phone: 716-689-0040 Fax: 716-568-2334 | |
Bradley Carrier, MD, MS Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2350 Maple Rd, Amherst, NY 14221 Phone: 716-688-6500 | |
Dr. Rakhi Shah Barkowski, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3980a Sheridan Dr Ste 200, Amherst, NY 14226 Phone: 716-852-4772 | |
Riffat Sadiq, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4979 Harlem Rd, Suite 1, Amherst, NY 14226 Phone: 716-923-4380 Fax: 716-923-4384 | |
Kristin Ann Matteson, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1306 Sweet Home Rd, Amherst, NY 14228 Phone: 716-838-3188 Fax: 716-838-1297 |